Specifically, compared with PD‐L1 Nb‐BiTE and HLA‐G Nb‐BiTE, the tumor growth inhibition was superior, and survival was prolonged significantly in mice after treatment with the dual‐targeting Nb‐TriTE in combination with PMBCs. The gene discussed is CD274; the disease is neoplasm.